The cough variant asthma
- Authors: Uryasjev M.O.1, Ponomareva I.V.1, Bhar M.1, Glotov S.I.1
-
Affiliations:
- Ryazan State Medical University
- Issue: Vol 92, No 3 (2020)
- Pages: 98-101
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/33917
- DOI: https://doi.org/10.26442/00403660.2020.03.000404
- ID: 33917
Cite item
Full Text
Abstract
Cough variant asthma (CVA) was first described by W. Corrao. CVA was described as the isolated chronic cough as the only presenting symptom responsive to bronchodilator therapy.This phenotype of asthma is present with airway hyperresponsiveness, eosinophilic inflammation airways and bronchodilator responsive coughing without typical manifestation of asthma such as wheezing or dyspnea. CVA shares common features with classic asthma such as eosinophilic inflammation and airway remodeling. Because of that, CVA is clinically considered as a variant type of asthma.
Full Text
##article.viewOnOriginalSite##About the authors
M. O. Uryasjev
Ryazan State Medical University
Email: docib@yandex.ru
ORCID iD: 0000-0001-8693-4696
д.м.н., проф., зав. каф. факультетской терапии с курсом терапии ФДПО
Russian Federation, RyazanI. V. Ponomareva
Ryazan State Medical University
Author for correspondence.
Email: docib@yandex.ru
ORCID iD: 0000-0002-0273-4388
к.м.н., доц. каф. факультетской терапии с курсом терапии ФДПО
Russian Federation, RyazanM. F. Bhar
Ryazan State Medical University
Email: docib@yandex.ru
ORCID iD: 0000-0001-6721-4634
аспирант каф. факультетской терапии с курсом терапии ФДПО
Russian Federation, RyazanS. I. Glotov
Ryazan State Medical University
Email: docib@yandex.ru
ORCID iD: 0000-0002-4445-4480
доц. каф. факультетской терапии с курсом терапии ФДПО
Russian Federation, RyazanReferences
- Исаева И.А., Урясьев О.М., Чунтыжева Е.Г. и др. Эффективность применения комплексов физических факторов у больных бронхиальной астмой с сопутствующей гипертонической болезнью. Наука молодых (Eruditio Juvenium). 2018;6(1):63-73 [Isaeva IA, Uryasyev OM, Chuntyzheva EG, et al. Effectiveness of application of complexes of physical factors in patients with bronchial asthma and comorbid essential hypertension. Nauka molodykh (Eruditio Juvenium) (In Russ.)]. doi: 10.23888/HMJ2018163-73
- Рогачиков А.И., Урясьев О.М. Техника ингаляции лекарственных средств и контроль над бронхиальной астмой. Российский медико-биологический вестник им. академика И.П. Павлова. 2016;24(3):86-91 [Rogachikov AI, Uryas’ev OM. The medication inhale technology and asthma control. Rossiiskii Mediko-Biologicheskii Vestnik im. akademika I.P. Pavlova. 2016;24(3):86-91 (In Russ.)]. doi: 10.17816/PAVLOVJ2016386-91
- Niimi A Geography and cough a etiology. Pulm Pharmacol Ther. 2007;20:383-7. doi: 10.1016/j.pupt.2006.10.014
- Marsden PA, Smith JA, Kelsall AA, et al. A comparison of objective and subjective measures of cough in asthma. J Allergy Clin Immunol. 2008;122:5903-7. doi: 10.1016/j.jaci.2008.08.029
- Corrao W, Braman S, Irwin R. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med. 1979;300:633-7. doi: 10.1056/nejm197903223001201
- Niimi A, Matsumoto H, Mishima M. Eosinophilic airway disorders associated with chronic cough. Pulm Pharmacol Ther. 2009;22:114-20. doi: 10.1016/j.pupt.2008.12.001
- Braman S, Corrao W. Chronic cough. Diagnosis and treatment. Prim Care. 1985;12:217-25. doi: 10.3928/0090-4481-19960301-09
- Birring SS, Parker D, Brightling CE, et al. Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med. 2004;169(1):15-9. doi: 10.1164/rccm.200308-1092OC
- Niimi A. Cough variant asthma: a major cause of chronic cough. Clin Pulm Med. 2008;15:189-96. doi: 10.1097/cpm.0b013e31817e3059
- Rabe KF, Adachi M, Lai CK, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40-7. doi: 10.1016/j.jaci. 2004.04.042
- Arakawa H, Hamasaki Y, Kohno Y, et al. Japanese guidelines for childhood asthma 2017. Allergol Inter. 2017;66(2):190-204. doi: 10.1016/j.alit.2016.11.003
- Niimi A, Matsumoto H, Takemura M, et al. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med. 2003;168(8):983-8. doi: 10.1164/rccm.200211-1268OC
- Fujimura M, Ogawa H, Nishizawa Y, Nishi K: Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? Thorax. 2003;58:14-8. doi: 10.1136/thorax.58.1.14
- Ioan I, Poussel M, Coutier L, et al. What is chronic cough in children? Front Physiol. 2014;5:322. doi: 10.3389/FPHYS.2014.00322
- Niimi A. Cough and asthma. Cur Respir Med Rev. 2011;7(1):47-54. doi: 10.2174/15733981179410932
- Morjaria B, Kastelik A. Unusual asthma syndromes and their management. Ther Advanc Chron Dis. 2011;2(4):249-64. doi: 10.1177/2040622311407542
- Masayuki H, Motoyasu I, Manabu S, Haruhito S. Smart Therapy for the initial treatement for cough variant asthma could lead to the improvement of adherence to therapy. Respirology. 2017;22:88-278. doi: 10.1111/resp.13207_215
- Fujimura M, Hara J, Myou S. Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: Effect of inhaled corticosteroids. Cough. 2005;I:5. doi: 10.1186/1745-9974-1-5
- De Diego A, Martinez E, Perpina M, et al. Airway inflammation and cough sensitivity in cough-variant asthma. Allergy. 2005;60(11):1407-11. doi: 10.1111/j.1398-9995.2005.00609
- Kanazawa H, Eguchi Y, Nomura N, Yoshikawa J. Analysis of vascularendothelialgrowth factor levels in inducedsputumsamplesfrom patients withcough variant asthma. Ann Allergy, Asthma Immunol. 2005;95(3):266-71. doi: 10.1016/S1081-1206(10)61224
- Liu M, Liu K, Zhu N, et al. Inflammatory mediators in induced sputum and airway hyperresponsiveness in cough variant asthma during long-term inhaled corticosteroid treatment. Mediat Inflamm. 2012;2012:403868. doi: 10.1155/2012/403868
- Mochizuki H, Arakawa H, Tokuyama K, Morikawa A. Bronchial sensitivity and bronchial reactivity in children with cough variant asthma. Chest. 2005;128(4):2427-34. doi: 10.1378/chest.128.4.2427
- Masayuki H, Motoyasu I, Manabu S, Haruhito S. SmartTherapy for the initial treatement for cough variant asthma could lead to the improvement of adherence to therapy. Respirology. 2017;22:88-278. doi: 10.1111/resp.13207_215
- Asano T, Takemura M, Fukumitsu K, et al. Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status. Allergol Intern. 2017;66(2):344-50. doi: 10.1016/j.alit.2016.08.015
- Shimoda T, Obase Y, Kishikawa R, et al. The fractional exhaled nitric oxide and serum high sensitivity C-reactive protein levels in cough variant asthma and typical bronchial asthma. Allergol Intern. 2013;62(2):251-7. doi: 10.2332/allergolint.12-OA-0515
- Ichinose M, Sugiura H, Nagase H, et al. Japanese guidelines for adult asthma 2017. Allergol Intern. 2017;66(2):163-89. doi: 10.1016/j.alit.2016.12.005
- Magni C, Chellini E, Zanasi A. Cough variant asthma and atopic cough. Multidisciplinary Respir Med. 2010;5(2):99-103. doi: 10.1186/2049-6958-5-2-99
- Sridaran S, Gonzalez-Estrada A, Aronica AM. A case of cough variant asthmaundiagnosed for 16 years. Operation and Maintenance Center – Radio. 2014;2014(2):29-30. doi: 10.1093/omcr/omu012
- Terasaki G, Paauw DS. Evaluation and treatment of chronic cough. Med Clin North Am. 2014;98(3):391-403. doi: 10.1016/j.mcna.2014.01.002
- Takemura M, Niimi A, Matsumoto H, et al. Clinical, physiological and anti-inflammatoryeffects of montelukast in patients withcough variant asthma. Respiration. 2012;83:308-1. doi: 10.1159/000332835
![](/img/style/loading.gif)